In addition, TNFAIP8 expression was increased in relapsed/refractory AML patients compared with newly-diagnosed AML patients, implicating a possible relationship between TNFAIP8 expression and chemotherapeutic response. This evidence concerns the gene TNFAIP8 and acute myeloid leukemia.